GastroAGI Logo
OverviewBlogsAbout
Trending TopicsConference
Topics/Endoscopy/Low-Volume PEG for Inpatient Colonoscopy: Annals of Internal Medicine | July 2026

Low-Volume PEG for Inpatient Colonoscopy: Annals of Internal Medicine | July 2026

Clinical knowledge base curated and reviewed by GastroAGI TeamLast updated July 1, 2026

Quick Answer

Introduction: Adequate bowel preparation is often difficult to achieve in hospitalized patients because of advanced age, comorbidities, immobility, and concurrent medications. This multicenter randomized INTERPRET trial compared 1-L, 2-L, and 4-L polyethylene glycol (PEG) regimens to determine the optimal bowel preparation for elective inpatient colonoscopy.


Introduction:

Adequate bowel preparation is often difficult to achieve in hospitalized patients because of advanced age, comorbidities, immobility, and concurrent medications. This multicenter randomized INTERPRET trial compared 1-L, 2-L, and 4-L polyethylene glycol (PEG) regimens to determine the optimal bowel preparation for elective inpatient colonoscopy.

Why was this study needed?

  • Inpatients frequently have inadequate bowel preparation.
  • Current guidelines continue to recommend high-volume PEG despite limited inpatient-specific evidence.
  • Poor bowel preparation increases missed lesions, repeat procedures, and healthcare costs.
  • Lower-volume preparations may improve patient acceptance and adherence.
  • Randomized evidence comparing different PEG volumes in hospitalized patients has been lacking.

Results:

  • 1-L PEG plus ascorbate achieved bowel cleansing comparable to 2-L and 4-L PEG while providing significantly better high-quality bowel preparation, particularly in the right colon.
  • Patients receiving 1-L PEG were the most willing to repeat the preparation, despite a slightly higher incidence of mild vomiting and thirst.
  • Overall safety was similar across all three regimens, with no major differences in serious adverse events.

Clinical Impact:

This landmark randomized trial challenges the routine use of high-volume bowel preparation in stable hospitalized patients. A split-dose 1-L PEG regimen appears to offer an excellent balance between efficacy, patient acceptance, and procedural quality, although caution remains necessary in patients with severe constipation, advanced kidney disease, or those requiring urgent colonoscopy.

Bottom Line:

For stable inpatients undergoing elective colonoscopy, 1-L PEG plus ascorbate provides the best balance of bowel cleansing quality and patient tolerability. These findings are likely to influence future bowel preparation guidelines and support broader adoption of low-volume regimens in hospitalized patients.

Related Q&A

Randomized Comparison of Endoscopic Gastroplasty Techniques for Obesity: Clinical Gastrointestinal Endoscopy | July 2026

Introduction: Endoscopic gastroplasty has emerged as an effective minimally invasive treatment for obesity, offering an alternative to bariatric surgery. Multiple endoscopic techniques are currently available, but comparative evidence has been limited. This randomized pragmatic trial...

Computer-Aided Detection (CADe) in Routine Colonoscopy: Gastroenterology | July 2026

Introduction: Adenoma detection rate (ADR) is the most important quality indicator for colonoscopy and is directly associated with reduced colorectal cancer risk. Although randomized trials have shown that artificial intelligence–based computer-aided detection (CADe) improves ADR,...

Cold vs Hot Snare Polypectomy for Pedunculated Colorectal Polyps: Endoscopy | July 2026

A randomized controlled trial published in Endoscopy (July 2026) compared cold snare polypectomy (CSP) with hot snare polypectomy (HSP) for small pedunculated colorectal polyps. ### Key findings - **CSP eliminated delayed post-polypectomy bleeding (DPPB)** and...

Novel Catheter Improves Endoscopic Transpapillary Gallbladder Drainage in Malignant Biliary Stricture VideoGIE | July 2026

Introduction: Acute cholecystitis in patients with malignant biliary obstruction can be difficult to manage, particularly when surgery is not feasible. Endoscopic transpapillary gallbladder drainage (ETGBD) is an attractive minimally invasive option, but selective cannulation of...

AI for Early Esophageal Cancer Detection: AJG | July 2026

Introduction: Early detection of esophageal squamous cell carcinoma (ESCC) is critical for curative endoscopic treatment. However, subtle lesions are often missed during routine endoscopy. This meta-analysis evaluated whether deep learning (AI)-based endoscopic systems can improve...

EndoBarrier Improves Diabetes and Weight Loss: Ann Surg | July 2026

Introduction: Endoscopic metabolic therapies have emerged as less invasive alternatives to bariatric surgery for patients with obesity and poorly controlled type 2 diabetes mellitus (T2DM). The EndoBarrier duodenal-jejunal bypass liner (DJBL) is an endoscopically placed...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersSoonFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer